PPP001

DRUG5 trials

Sponsors

Tetra Bio-Pharma

Conditions

Breakthrough Cancer PainCancerCancer PainCannabis UseChronic Pain Due to Malignancy (Finding)Healthy VolonteersHealthy VolunteersPain, Acute

Phase 1

Safety and Pharmacokinetics of Smoked Cannabis in Healthy Patients

CompletedNCT04314804

Tetra Bio-PharmaHealthy Volunteers

Start: 2017-03-01End: 2017-11-16Updated: 2020-03-25

Safety and Pharmacokinetics of Vaped Cannabis in Healthy Volunteers

CompletedNCT04461756

Tetra Bio-PharmaHealthy Volonteers

Start: 2018-11-01End: 2018-11-24Updated: 2020-07-10

Phase 2

Inhaled Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain

Tetra Bio-PharmaBreakthrough Cancer Pain, Cancer

Start: 2021-05-26End: 2022-04-30Target: 20Updated: 2021-07-28

Safety and Efficacy of Inhaled Cannabis For the Uncontrolled Pain Relief in Patients With Advanced Cancer

Tetra Bio-PharmaCancer Pain, Cannabis Use, Pain, Acute +1

Start: 2020-07-30End: 2022-09-30Target: 78Updated: 2021-09-16

Phase 3

Safety and Efficacy of Smoked Cannabis for Improving Quality of Life in Advanced Cancer Patients

TerminatedNCT03339622

Tetra Bio-PharmaCancer, Chronic Pain Due to Malignancy (Finding)

Start: 2018-03-29End: 2019-02-08Updated: 2019-10-09